May 14 (Reuters) - CareDx Inc:
* CAREDX AND VERACYTE ANNOUNCE EXCLUSIVE PARTNERSHIP FOR TRANSPLANT REJECTION TESTING ON NCOUNTER SYSTEM
* CAREDX INC - CO WILL BECOME EXCLUSIVE WORLDWIDE COMMERCIALIZATION PARTNER FOR SOLID ORGAN TRANSPLANT-REJECTION TESTS ON VERACYTE’S DIAGNOSTIC PLATFORM Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.